secwatch.observer — SEC 8-K summary
======================================

Issuer:     YIELD10 BIOSCIENCE, INC. (—)
CIK:        0001121702
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001121702-24-000045
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Yield10 Q1 2024 net loss $2.5M, improves cash burn; milestone payments received
-------------------------------------------------------------------------------

- Cash at $1.6M (up from $1.1M Dec 2023); operating cash burn $0.9M vs $2.7M YoY.
- Recognized $0.3M license revenue from VISION; received $2M initial payment, additional $1M milestone in May 2024.
- Net loss $2.5M ($4.77 diluted share) compared to $3.8M ($18.16) in Q1 2023; results reflect 1-for-24 reverse split.
- EPA approved INTERLINE herbicide for Camelina; USDA-APHIS cleared commercial planting of HT Camelina.
- Building omega-3 Camelina seed inventory for aquafeed; patent granted for carbon fixation pathway and notice of allowance for yield trait C3004.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1121702/000112170224000045/0001121702-24-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1121702/000112170224000045/yten-20240515.htm
  HTML page:      https://secwatch.observer/filing/0001121702-24-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer